» Authors » Keiichi Mitsuyama

Keiichi Mitsuyama

Explore the profile of Keiichi Mitsuyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 129
Citations 1792
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuruta K, Takedatsu H, Yoshioka S, Yoshikai M, Tomiyasu K, Morita M, et al.
Digestion . 2023 Jul; 104(6):430-437. PMID: 37437555
Introduction: Small bowel tumors (SBTs) are difficult to diagnose because of limited opportunities and technical difficulties in evaluating the small bowel. Asymptomatic conditions or nonspecific symptoms make SBT diagnosis more...
2.
Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J . 2023 Apr; 68(2):43-52. PMID: 37100606
Background: Immune checkpoint inhibitors (ICIs) including anti-CTLA-4, anti-PD-1, and anti-PD-L1 antibodies have been increasingly used for various malignancies. These ICIs activate immune functions to treat malignant tumors; however, this causes...
3.
Yasuda R, Arai K, Kudo T, Nambu R, Aomatsu T, Abe N, et al.
J Gastroenterol Hepatol . 2023 Mar; 38(7):1131-1139. PMID: 36880154
Background And Aim: Serum leucine-rich alpha-2 glycoprotein (LRG) and calprotectin have been studied as disease activity markers in adults with inflammatory bowel disease (IBD). We evaluated them in pediatric IBD...
4.
Morita M, Takedatsu H, Yoshioka S, Mitsuyama K, Tsuruta K, Kuwaki K, et al.
J Clin Med . 2022 Oct; 11(19). PMID: 36233615
Background: The roles and methods of diagnostic colonoscopy in pediatric patients were previously demonstrated. With advances in medical equipment and the increasing need for pediatric endoscopic diagnosis, we compared recent...
5.
Hisanaga H, Takedatsu H, Emori K, Inoue H, Kunitake Y, Nakane T, et al.
Medicina (Kaunas) . 2022 Aug; 58(8). PMID: 36013545
Aim: In patients with hepatitis C virus-related liver cirrhosis (LC) who achieve sustained virological responses (SVRs) through treatment with direct-acting antiviral agents (DAAs), it remains unclear whether there are improvements...
6.
Kinugasa T, Mitsuyama K, Murotani K, Mizobe T, Ochi T, Yoshimura T, et al.
Kurume Med J . 2022 Aug; 67(2.3):57-63. PMID: 35944985
Background: Fecal calprotectin (FC) is the most widely used marker for evaluating the disease activity of ulcerative colitis (UC). However, studies on FC in pouchitis after total proctocolectomy are scarce....
7.
Kita T, Ashizuka S, Takeda T, Matsumoto T, Ohmiya N, Nakase H, et al.
J Gastroenterol Hepatol . 2022 Jul; 37(11):2051-2059. PMID: 35840351
Background And Aim: Adrenomedullin is a bioactive peptide with many pleiotropic effects, including mucosal healing and immunomodulation. Adrenomedullin has shown beneficial effects in rodent models of inflammatory bowel disease and,...
8.
Arinaga-Hino T, Ide T, Akiba J, Suzuki H, Kuwahara R, Amano K, et al.
Sci Rep . 2022 May; 12(1):8759. PMID: 35610317
Growth differentiation factor 15 (GDF15) has been reported to be associated with fibrosis and cancer in liver disease. Diagnosis of autoimmune hepatitis (AIH) is often difficult because of the lack...
9.
Fukunaga S, Nakano D, Tsutsumi T, Kawaguchi T, Eslam M, Yoshinaga S, et al.
Hepatol Res . 2022 May; 52(8):699-711. PMID: 35585481
Aim: Reflux esophagitis is associated with metabolic dysfunction. Recently, fatty liver has been redefined as metabolic dysfunction-associated fatty liver disease (MAFLD). We investigated the impact of MAFLD and its subtypes...
10.
Imakiire S, Takedatsu H, Mitsuyama K, Sakisaka H, Tsuruta K, Morita M, et al.
Gut Liver . 2022 Jan; 16(1):92-100. PMID: 35027509
Background/aims: Proteinase 3 antineutrophil cytoplasmic antibody (PR3-ANCA) is a serologic marker for granulomatosis with polyangiitis. However, recent studies have also shown their role as diagnostic markers for ulcerative colitis (UC)....